Laboratory Assessment of Direct Oral Anticoagulants

Jonathan Douxfils, Robert C Gosselin

Research output: Contribution to journalReview articlepeer-review


Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.

Original languageEnglish
Article number02401
Pages (from-to)277-290
Number of pages14
JournalSeminars in thrombosis and hemostasis
Issue number3
Publication statusPublished - 1 Apr 2017
Externally publishedYes


  • activated partial thromboplastin time
  • anti-Xa
  • apixaban
  • dabigatran
  • dilute thrombin time
  • Ecarin
  • edoxaban
  • prothrombin time
  • rivaroxaban


Dive into the research topics of 'Laboratory Assessment of Direct Oral Anticoagulants'. Together they form a unique fingerprint.

Cite this